Sequential molecularly targeted drug therapy including axitinib for a patient with end-stage renal failure and metastatic renal cell carcinoma-Reference-Cited by-同舟云学术

Sequential molecularly targeted drug therapy including axitinib for a patient with end-stage renal failure and metastatic renal cell carcinoma

Published:2015-08-25 Issue:2 Volume:20 Page:E1-E4
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:Hemodialysis International

Author:

Nishida Hayato¹,Fukuhara Hiroki¹,Yamagishi Atsushi¹,Sakurai Toshihiko¹,Shibasaki Tomohiro¹,Kawazoe Hisashi¹,Kato Tomoyuki¹,Tomita Yoshihiko²

Affiliation:

1. Department of Urology; Yamagata University Faculty of Medicine; Iida-nishi Yamagata Japan

2. Division of Urology, Department of Regenerative and Transplant Medicine; Graduate School of Medical and Dental Sciences; Niigata University; Niigata Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hdi.12329/fullpdf

Reference16 articles.

1. Present status of renal cell carcinoma in dialysis patients in Japan: questionnaire study in 2002;Ishikawa;Nephron Clin Pract,2004

2. Renal cell carcinoma detected by screening shows better patient survival than that detected following symptoms in dialysis patients;Ishikawa;Ther Apher Dial,2004

3. Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care;Bex;BJU Int,2012

4. Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis;Josephs;BJU Int,2011

5. Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center;Kennoki;Jpn J Clin Oncol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment;Urologic Oncology: Seminars and Original Investigations;2023-11

2. Approach to Special Populations with Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

3. Combination Therapy of Pembrolizumab plus Axitinib for a Patient on Hemodialysis with Metastatic Renal Cell Carcinoma: A Case Report;Case Reports in Oncology;2021-10-22

4. Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review;Seminars in Oncology;2020-04

5. Efficacy and safety of axitinib for metastatic renal cell carcinoma in patients on hemodialysis for end‐stage renal disease: Case series of eight patients;International Journal of Urology;2019-08-25